TP53 and neoplasm: 4 of these genes (PTEN, RB1, TP53 and RUNX1) are known tumor suppressors and have also been identified as potential point mutation driver genes [23], showing that in BRCA1/2-mutated tumors, structural variants often inactivate the same drivers that are normally damaged by point mutations in sporadic tumors.